5-BROMO-2,3-DIHYDRO-BENZO[D]ISOTHIAZOLE 1,1-DIOXIDE, 95.0%, 1g

METHYL 3-HYDROXY-3-(3-HYDROXYPHENYL)PROPANOATE, 95.0%, 100mg

5-(3-Fluorophenyl)oxazole, 96.0%, 5g

Plan PLi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm

(3-((2,2,2-Trifluoroethoxy)methyl)phenyl)boronic acid, 98+%, 1g

1,3,5-Tris(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzene>98.0%(GC)(T)5g

ICP-MS multi-element standard solution, 500mL, 22 elements in 2% nitric acid

5-Bromo-4-cyclopropyl-6-methoxypyrimidine, 97%, 10g

6-Fluoro-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride, 97%, 50mg

2-(Dimethylamino)-6-methylbenzaldehyde, 98%, 250mg

Ethyl 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoate, 98%, 250mg

2-Methylcyclopropanecarboxylic acid, 97.0%, 5g

Scintillation vials, 5 ml, 2000 Piece(s)